5. NYT on cases vs. deaths in Europe. And the FT on the Finnish success. And FT on the Madrid second wave, and a contrast with NYC. Doesn’t settle the key issues, but a good overview.
7. The nasal spray, which will be entering clinical trials.
3. Ross Douthat on the Ginsburg seat (NYT).
4. “In short, academic institutions systemically promote exactly the sort of short-term optimization of which, ironically, the private sector is often accused. Is entrepreneurship a trap? No; right now, it’s one of the only ways to avoid being trapped.” Link here.
1. More American soft power: it seems BLM is one reason why Barbados might cast off its ties to Queen Elizabeth (NYT).
5. Joel Miller on whether we should accelerate infections in low-risk persons. It does not sufficiently address the economic (and thus also human) benefits of a speedier resolution, but nonetheless makes some good points.
4. Messi vs. Massi: “Footballer Lionel Messi can register his name as a trademark after a nine-year legal battle, the EU’s top court has ruled.”
6. The making of a Harvard department chair (somewhat depressing, actually). “Nearly half of the 40 department chairs in Harvard’s Faculty of Arts and Sciences received tenure within Harvard and nearly three-quarters have been teaching at the University for more than 15 years, an analysis by The Crimson found.”
3. “What I think I am nearly certain about,” redux of a 2008 post.
2. The philanthropy of Chuck Feeney who gave it all away (link fixed now).
4. Kanye to the NYT: “He also expressed anguish about abortion, said he didn’t reflexively support Democrats, and asked, “Does anyone at your magazine believe in Jesus?”” (link is NYT as well — they do not report their answer to that question).
2. Anger increases susceptibility to misinformation. When I see all you “pro-science” types getting mad at the wrongdoers, mostly I get sad and think you are turning your back on your cause.
4. What kind of euro-based arbitrage scheme is this!? Sorry W.S. Jevons!
3. You people are so embarrassing. But apparently not embarrassed.
5. The Sturgis Bike Rally paper does seem quite wrong, and perhaps the authors and the NBER should withdraw it?
7. “Our model predicts that moderately efficacious masks that reduce transmission risk by 50% will lower exposure viral load 10-fold among people who do get infected, potentially limiting infection severity.” Link here.
1. Gottlieb and McClellan, both former FDA heads, call for accelerated vaccine approval for designated groups, without relaxation of broader standards (WSJ).
6. Open-air winter schools in New England, in pre-complacency times.
7. Life on Venus? No one cares about that either…(NYT) As a kid I was convinced there was life on Venus, and was never persuaded by the impossibility arguments. So today (while this remains uncertain) I am feeling ever so slightly vindicated in one of my earlier specific beliefs.
3. The Viewer (recommended videos, affiliated with The Browser).
3. Why is Pakistan doing better than India with respect to Covid-19? (speculative)
6. Heart disease in Covid athletes: the basic claims are still falling apart.
2. People are grinding their teeth more (NYT).
3. It seems Marshall Islands is doing an all-digital currency with a Friedmanite growth rule. With Patri Friedman on an advisory board.
5. And Kyle Lowry. A mini-essay on cognition, recommended for those who care.
2. Topol and Offit on vaccines. Excellent material, but it is striking how conservative Offit is when it comes to means of responsibly accelerating knowledge about vaccines. Not a peep about market incentives, for one thing. WWJBS?
3. More detail on the Taiwanese Covid response, especially from the tech side.